BioCad Medical Inc. is a privately held company headquartered in Quebec City, Canada. Acquired by Nobel Biocare Holding AG on November 11, 2008, BioCad specializes in the development of advanced medical prosthetic software and complementary products. The company provides a robust platform of software and manufacturing expertise, focusing on esthetics and implantology, to design and manufacture a diverse range of prosthetic elements for the dentistry market. With a foundation built on 35 years of extensive dental laboratory and implantology experience, BioCad's products and solutions include innovative prosthetic software, overdenture bars, and implant bridges. Employing many highly skilled professionals, including medical software engineers, dental technicians, and industrial manufacturing specialists, BioCad serves a rapidly growing customer base primarily in Canada and North America.

Disease Domain	Count

Neoplasms	7
Immune System Diseases	7
Infectious Diseases	6
Nervous System Diseases	4
Hemic and Lymphatic Diseases	3
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Monoclonal antibody	10
Interferons	7
Biosimilar	7
Small molecule drug	4
Prophylactic vaccine	2

Top 5 Target	Count

IFNAR(Interferon alpha/beta receptor)	5
TNF-α(Tumor necrosis factor α)	2
HER2(Receptor tyrosine-protein kinase erbB-2)	2
VEGF-A(Vascular endothelial growth factor A)	1
IL-6RA(Interleukin-6 receptor alpha subunit)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 15 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Bevacizumab biosimilar(Biocad Medical, Inc.) ( VEGF-A )	Non-Small Cell Lung Cancer More	Approved
Trastuzumab biosimilar(Biocad Medical, Inc.) ( HER2 )	Breast Cancer More	Approved
Rituximab biosimilar(Biocad Medical, Inc.) ( CD20 )	Non-Hodgkin Lymphoma More	Approved
Infliximab biosimilar(Biocad Medical, Inc.) ( TNF-α )	Rheumatoid Arthritis More	Approved
Interferon beta-1a biosimilar(Biocad Medical, Inc.) ( IFNAR )	Multiple Sclerosis More	Approved

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis